Get 20% lifetime commission for referring investors to digrin.com
here.
Replimune Group, Inc. ( REPL) - Stock Earnings
REPL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -70.9 million USD | — USD |
| 2026Q1 | -73.2 million USD | — USD |
| 2026Q2 | -69.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
REPL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -215.8 million USD | — USD |
| 2025 | -247.3 million USD | — USD |
| 2026 | -313.9 million USD | — USD |
| 2026 Est. | — | — |
REPL
Price: $14.63
52 week price:
Earnings Per Share: -3.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 354500
Market Capitalization: 1.4 billion